I can’t be the only one who feels stuck on a Bill Murray nightmare time loop.
The name of the game here is “publicly subsidized, privately profitable.”
And no one plays it better than a certain Bill Gates-funded entity that emerged out of nowhere to become a pharmaceutical powerhouse during COVID-19.
Related: HHS Set to Roll Out Bird Flu Vaxes by the Millions
Via Associated Press (emphasis added):
The U.S. government will pay the vaccine maker Moderna $176 million to accelerate development of a pandemic influenza vaccine that could be used to treat bird flu in people, as concern grows about cases in dairy cows across the country*, federal officials announced Tuesday.
Moderna already has a bird flu vaccine in very early-stage testing that uses the same mRNA technology that allowed rapid development and rollout of vaccines to protect against COVID-19. The new funds from the U.S. Department of Health and Human Services include continued development of the vaccine, including a late-stage trial next year if those early study results are positive.
But the project can be quicky redirected to target another form of influenza if a different threat than the H5N1 form of bird flu emerges, HHS officials stressed.
*Concerns that corporate state media that relies on pharmaceutical industry advertising revenue are fueling.
Will any of Moderna’s massive windfall profits (guaranteed by government mandates, in all likelihood) be returned to the national treasury with interest for the $176 million gift?
“Let’s not be [naïve] children,” to quote Trump from the last debate with Biden over who is the better golfer.
One recalls that the NIH employees who collaborated with Moderna on its COVID-19 shot scam received in excess of $400 million in kickbacks as payment for a job well done.
Via The Epoch Times (emphasis added):
The U.S. National Institutes of Health (NIH) is refusing to release additional information about an agreement it reached over a COVID-19 vaccine that has earned it at least $400 million.
The NIH declined to provide any materials in response to a Freedom of Information Act request from The Epoch Times.
“The NIH withholds the entirety of the records as they are protected from release,” Gorka Garcia-Malene, an NIH officer, told The Epoch Times in a letter.
She cited an exemption outlined in the act that allows government agencies to partially or fully withhold information.
“In this case, exemption 3 incorporates 35 U.S.C. 209 (f), which reads in relevant part, ‘No Federal agency shall grant any license under a patent or patent application on a federally owned invention unless the person requesting the license has supplied the agency with a plan for development or marketing of the invention, except that any such plan shall be treated by the Federal agency as commercial and financial information obtained from a person and privileged and confidential and not subject to disclosure under section 552 of title 5,’” Ms. Garcia-Malene wrote.
“Exemption 4 protects from disclosure trade secrets and commercial or financial information that is privileged and confidential,” she added.
In February 2023, Moderna announced that it had paid $400 million to the NIH and would make additional payments in the future as part of a licensing agreement for spike proteins used in the company’s COVID-19 vaccine. The Epoch Times obtained a copy of the contract, which confirmed the payment but redacted details of the future payments.
The Epoch Times then lodged a new request, seeking more details about the future payments, which are said to be based on how many COVID-19 vaccines are sold.
So some crooked NIH operatives are also likely about to get rich(er) off of the government graft gravy train.
I would go with the classic “your tax dollars at work" line, but that’s not really how things work. Almost half of your personal tax dollars go solely to servicing the interest on the national debt — not the national debt itself, but the interest on the debt.
The money the government funnels to Moderna for mRNA gene therapy shots and indirectly to NIH employees as kickbacks — or anything else it wastes money on with no true public benefit — doesn’t actually come from tax revenue collected by the IRS; it’s “money” (loosely defined) printed out of thin air and piled on top of the national debt for future generations to deal with.
